New

C12.ai

The AI engine Fit Assessment

Beta

The company provides AI-enabled laboratory automation and drug discovery workflows tailored for pharmaceutical research, aligning with the pharma tech central requirement.

Blurb

C12.ai is a company developing "physics AI scientists".

HQ Location

Shanghai (China)

Founded

2022

Employees

11 - 50

Total funding raised

$7.28M

Funding Status

Seed, $7.28M, March 12, 2026

Provider of intelligent laboratory automation services intended for pharmaceutical research purposes. The company offers artificial intelligence for drug discovery workflows, embodied intelligence for robotic handling, and advanced data processing capabilities, enabling pharmaceutical laboratories to reduce reliance on manual operations, improve reproducibility of experiments, and accelerate development timelines.